About WHAT WE DO WHAT WE'VE ACHIEVED CONTACT WHAT WE'VE ACHIEVED The partners at Prospect Ventures have led investments in more than 50 companies and have an established track record of working closely with management teams in early and growth stage enterprises. These private and public companies have achieved substantial clinical and commercial success in their industry segments and have generated superior investment returns for Prospect Venture Partners funds. Notable investments include Amicus Therapeutics (NASDAQ: FOLD), Amira Pharmaceuticals (NYSE: BMS acquired), Aveo Pharmaceuticals (NASDAQ: AVEO), Cabochon (Merz acquired), Complete Genomics (NASDAQ: GNOM), Gloucester Pharmaceuticals (NASDAQ: CELG acquired), Healtheon (NASDAQ: WBMD merged), Idun Pharmaceuticals (NYSE: PFE acquired), Infinity Pharmaceuticals (NASDAQ: INFI), Intuitive Surgical (NASDAQ: ISRG), Jazz Pharmaceuticals (NASDAQ: JAZZ), Kythera Biopharmaceuticals (NYSE: AGN acquired) Millennium Pharmaceuticals (Takeda Pharmaceutical acquired), NGM Biopharmaceuticals, Ninepoint Medical, Novacept (NASDAQ: HOLX acquired), Opus Medical (NASDAQ: ARTC acquired), Portola Pharmaceuticals (NASDAQ: PTLA), SentreHeart, Rinat Neuroscience (NYSE: PFE acquired), Senomyx (NASDAQ: SNMX), SurgRx (NYSE: JNJ acquired), Tercica (NYSE: IPN acquired), Tinea Pharmaceuticals (NASDAQ: VRX acquired), Transave (NASDAQ: INSM), Trubion (NYSE: EBS acquired), Visiogen (NYSE: ABT acquired) and Vitae Pharmaceuticals (NYSE: AGN acquired). Contact Prospect Venture Partners: Address: 525 University Ave., Suite 1350 Palo Alto, CA 94301 Phone: (650) 327-8800 Prospect Ventures Funds: Prospect Venture Partners I Prospect Venture Partners II Prospect Venture Partners III Connect with Prospect Ventures: Prospect Ventures on LinkedIn Prospect Ventures on Crunchbase Prospect Ventures on Bloomberg Prospect Ventures on CB Insights Prospect Ventures on Palico Prospect Ventures on Index.co Prospect Bio Ventures © 2018 - Prospect Venture Partners.. All Rights Reserved No content on this site may be republished or reprinted without written permission from Prospect Venture Partners

About WHAT WE DO WHAT WE'VE ACHIEVED CONTACT CALL OR VISIT 525 University Ave, Suite 1350 Palo Alto, CA 94301 (650-327-8800) Monday – Friday: 9AM – 5PM EMAIL Limited Partner Inquiries to CFO, Prospect Venture Partners, Tom Muscarella tmuscarella@prospectventures.com SOCIAL Prospect Venture Partners on LinkedIn © 2018 - Prospect Venture Partners.. All Rights Reserved No content on this site may be republished or reprinted without written permission from Prospect Venture Partners